Our symposium aims to serve as a resource for stakeholders, addressing challenges from political, social, and health perspectives. We strive to influence policy, advocate globally, and ensure equitable access to treatments and care for those affected by MPS and related diseases.
The IMPSN Florence 2026 Symposium brings together families, healthcare professionals, researchers, and industry leaders to accelerate progress in mucopolysaccharidoses (MPS) and related lysosomal storage disorders through collaborative innovation.
We unite diverse perspectives to advance early diagnosis through cutting-edge technologies, develop revolutionary therapies, and ensure equitable global access to care. Our mission is to foster the next generation of rare disease advocates and professionals while creating sustainable partnerships that transform scientific breakthroughs into real-world improvements in patient outcomes worldwide.
To establish a new paradigm for rare disease care where the powerful collaboration between families and professionals serves as a global model for accelerating medical progress.
We envision a future where advanced technologies enable rapid, accurate diagnosis from birth; where revolutionary treatments are accessible to every patient regardless of geography or economic circumstances; and where the MPS community’s innovative approaches inspire and guide progress across all rare diseases.
Through the Florence Declaration, we will launch a unified global network that ensures no patient waits years for answers, no breakthrough remains confined to laboratories, and no family faces their journey alone.
Our vision extends beyond MPS to create a replicable framework that transforms rare disease care into a field of limitless possibility and hope.
Via Paolo Emilio, 7 – 00192 Rome
T. + 39 06.455505560 – info@mps2026.com
Piazza della Vittoria, 29 – 06049 Spoleto (PG) Italy
T. +39 0743.21818 – travel@mps2026.com